Yahoo · Oct 23, 2026
ELV vs. RVTY: Which Stock Is the Better Value Option?
ELV vs. RVTY: Which Stock Is the Better Value Option?
NYSE · RVTY
Revvity, Inc.
Healthcare · Medical - Diagnostics & Research
$157.00
Down-$8.78 (-5.30%)
Updated Oct 31, 2026, 5:52 PM
SID Score
6.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 12.32B
- P/E ratio
- 51.31
- Dividend yield
- 0.22%
- 52-week range
- $81.22 – $169.06
- Volume
- 3.18M
- Avg. volume
- 1.43M
Price performance · RVTY
RVTY price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
RVTY closed at $157.00 after 21 trading sessions, up 3.61% for the selected period.
- Last close
- $157.00
- Period change
- +3.61%
- Period low
- $150.94
- Period high
- $165.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $164.21 | $164.21 | $155.81 | $157.00 | 3.18M |
| Oct 29, 2026 | $165.32 | $167.30 | $163.05 | $165.78 | 1.53M |
| Oct 28, 2026 | $163.00 | $169.06 | $162.85 | $165.33 | 2.18M |
| Oct 27, 2026 | $158.82 | $162.76 | $156.28 | $161.86 | 1.55M |
| Oct 26, 2026 | $159.37 | $161.67 | $159.10 | $160.39 | 1.09M |
| Oct 23, 2026 | $156.35 | $159.05 | $152.73 | $158.77 | 1.11M |
| Oct 22, 2026 | $156.18 | $161.64 | $154.87 | $157.36 | 1.78M |
| Oct 21, 2026 | $154.44 | $159.48 | $152.71 | $156.61 | 2M |
| Oct 20, 2026 | $152.64 | $157.575 | $152.19 | $156.01 | 1.4M |
| Oct 19, 2026 | $153.89 | $156.8673 | $150.71 | $150.94 | 1.26M |
| Oct 16, 2026 | $154.44 | $155.50 | $151.61 | $152.64 | 1.34M |
| Oct 15, 2026 | $151.91 | $156.86 | $148.83 | $154.71 | 2.37M |
| Oct 14, 2026 | $154.26 | $158.00 | $151.45 | $152.12 | 2.02M |
| Oct 13, 2026 | $156.44 | $157.46 | $153.10 | $155.08 | 1.39M |
| Oct 12, 2026 | $153.74 | $156.33 | $153.46 | $155.61 | 1.12M |
| Oct 9, 2026 | $152.40 | $155.50 | $152.40 | $154.18 | 1.22M |
| Oct 8, 2026 | $152.04 | $152.54 | $146.70 | $152.16 | 1.46M |
| Oct 7, 2026 | $153.03 | $156.01 | $149.25 | $153.60 | 2.23M |
| Oct 6, 2026 | $161.62 | $166.25 | $151.45 | $153.30 | 2.68M |
| Oct 5, 2026 | $151.45 | $157.45 | $150.385 | $157.36 | 1.55M |
| Oct 2, 2026 | $149.94 | $153.375 | $148.55 | $151.53 | 1.24M |
Latest RVTY news
The latest Smart Investors Daily articles mentioning RVTY.
Stock researchCompany · Overview
Company
Market Activity
Research & News
RVTY research
Overview
Company profile and research snapshot.
Company profile
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $110.25
- Implied upside
- —
- Analysts
- 25
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Buy | — |
| Oct 7, 2026 | Barclays | Equal-Weight | — |
| Oct 6, 2026 | William Blair | Outperform | — |
| Sep 4, 2026 | Keybanc | Overweight | — |
| Sep 1, 2026 | RBC Capital | Sector Perform | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 20, 2026
Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
WALTHAM, Mass., October 20, 2026--Revvity, Inc. (NYSE: RVTY), announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.
Yahoo · Oct 16, 2026
1 Cash-Producing Stock to Own for Decades and 2 We Question
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Yahoo · Oct 15, 2026
Revvity (RVTY), What Is Drawing Fresh Attention Now?
Revvity (RVTY) is back on investor calendars after announcing third quarter 2026 results are due on 3 November, with earnings per share expected to be higher and fresh conference appearances scheduled soon after. Revvity’s share price has surged over the past quarter, with a 30 day share price return of 18.4% and a 90 day gain of 36.2%. The 1 year total shareholder return of 65.6% contrasts with a weaker 5 year total shareholder return that is still down 12.8%, suggesting momentum has...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
